Ovarian Cancer | Specialty

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Dr. O'Malley on Folate-Receptor Alpha as a Biomarker in Ovarian Cancer

August 10th 2018

David O'Malley, MD, professor, Department of Obstetrics and Gynecology, The Ohio State University Comprehensive Cancer Center, discusses folate-receptor alpha as a biomarker in ovarian cancer.

Tumor Treating Fields Show Promise in Ovarian Cancer

August 7th 2018

In combination with weekly paclitaxel, tumor treating fields, an antimitotic therapy that delivers continuous low-intensity electrical fields to the tumor region, has been found safe in platinum-resistant ovarian cancer.

Dr. Konecny on Response to PARP Inhibitors in Ovarian Cancer

August 3rd 2018

Gottfried E. Konecny, MD, associate professor of medicine, University of California, Los Angeles, discusses response to PARP inhibitors in ovarian cancer.

Novel Frontline Regimens Are Emerging for Advanced Ovarian Cancer

August 2nd 2018

Bradley J. Monk, MD, and other gynecologic oncology experts from across the United States discussed how new evidence has affected their approach to treating advanced ovarian cancer.

Dr. McCann on Resistance Mutations in Ovarian Cancer

July 31st 2018

Kelly McCann, MD, PhD, a medical oncologist in the Breast Cancer Research Group at the University of California, Los Angeles, discusses resistance mutations in ovarian cancer.

Improvements in Advanced Ovarian Cancer

July 27th 2018

Novel Treatment Strategies in Recurrent Ovarian Cancer

July 27th 2018

PARP Combination Therapies in Ovarian Cancer

July 27th 2018

Ongoing PARP Trials in Recurrent Ovarian Cancer

July 27th 2018

Recurrent Ovarian Cancer: PARP Inhibitors Compared

July 27th 2018

Using Maintenance Therapy in Recurrent Ovarian Cancer

July 27th 2018

PARP Maintenance Therapy in Recurrent Ovarian Cancer

July 27th 2018

A New Standard of Care in Recurrent Ovarian Cancer?

July 27th 2018

The GOG-0213 Trial in Recurrent Ovarian Cancer

July 27th 2018

Using Novel Therapies in Advanced Ovarian Cancer

July 27th 2018

Advanced Ovarian Cancer: Emerging Therapies

July 27th 2018

Targeting VEGF in Advanced Ovarian Cancer

July 27th 2018

Neoadjuvant Therapy in Advanced Ovarian Cancer

July 27th 2018

Surgical Controversies in Advanced Ovarian Cancer

July 27th 2018

Molecular Testing in Ovarian Cancer

July 27th 2018